PC-Merz: antiparkinsonian and antiviral agent
PC-Merz is a drug used for the treatment of Parkinson's disease and parkinsonism, as well as for chemoprophylaxis and treatment of influenza A virus. It belongs to the group of antiparkinsonian dopaminergic drugs and is manufactured by Merz Pharma in Germany. The international name of the drug is amantadine.
PC-Merz is available in several dosage forms, including 100 mg film-coated tablets, 200 mg infusion solution and 100 mg tablets. The active substance is amantadine.
Indications for the use of PC-Merz include the treatment of Parkinson's disease, parkinsonism (including postencephalic and symptomatic with carbon monoxide poisoning and cerebral atherosclerosis) and chemoprophylaxis and treatment of influenza A virus.
However, PC-Merz also has contraindications. You should not take the drug if you have hypersensitivity to its components, acute and chronic diseases of the liver and kidneys, pregnancy (especially in the first trimester), lactation, glaucoma, prostate adenoma, thyrotoxicosis, epilepsy, psychomotor agitation, psychosis, predelirium or delirium.
Side effects of PC-Merz may include headache, irritability, hallucinations, insomnia, dyspepsia, anxiety, anorexia, xerostomia, peripheral edema and orthostatic hypotension.
You should be careful when using PK-Merz if you have heart failure or circulatory problems. Elderly patients are recommended to reduce the dose, and the drug should be discontinued gradually to avoid a sharp exacerbation of the disease. During treatment with PK-Merz you should not drink alcohol. It is also necessary to be careful when prescribing the drug to patients whose work requires increased attention and reaction speed.
The interaction of PK-Merz with other drugs can lead to an increased effect of central nervous system stimulants. It is also compatible with central anticholinergics and other antiparkinsonian drugs. There is no information about an overdose of PC-Merz.
Thus, PK-Merz is a drug that can help in the treatment of Parkinson's disease, parkinsonism and influenza